OVESCO ENDOSCOPY AG

Their core work

Ovesco Endoscopy is a German medical device SME specializing in endoscopic tools and technologies for gastrointestinal diagnosis and intervention. Based in Tübingen, they develop and commercialize instruments used in colonoscopy and gastroenterology procedures. Within EU research consortia, they contribute industry expertise in endoscope design, clinical device integration, and translating laboratory imaging techniques into point-of-care diagnostic instruments — particularly for colorectal cancer detection.

What they specialise in

How they've shifted over time

Their early H2020 involvement (2015–2019) centered on mechanical and connectivity aspects of endoscopy — robotic guidance systems (Endoo) and wireless in-body communication (WiBEC). By 2020, their focus shifted decisively toward advanced optical diagnostics, with PROSCOPE combining multiple imaging modalities (OCT, Raman spectroscopy, two-photon microscopy) for real-time colorectal cancer detection. This trajectory shows a move from device mechanics toward intelligent, image-guided diagnosis at the point of care.

Ovesco is moving toward AI-compatible, multimodal optical diagnostic instruments for gastroenterology — expect continued work in image-guided intervention and point-of-care cancer screening.

How they like to work

Ovesco consistently participates as a specialist industry partner rather than leading consortia, which is typical for an SME contributing commercial device expertise to research-driven projects. With 28 unique partners across 9 countries over just 3 projects, they operate in medium-to-large consortia and do not appear to repeat partners frequently, suggesting openness to new collaborations. Their role is that of the industry endpoint — bringing clinical product knowledge and commercialization potential to academic-led research.

Ovesco has collaborated with 28 distinct partners across 9 European countries through their three H2020 projects, indicating a broad but not deeply repeated network. Their consortia are research-heavy, likely anchored by university hospitals and photonics research groups.

What sets them apart

Ovesco occupies a rare position as an established endoscopy device manufacturer actively engaged in EU-funded research — most medical device SMEs either do R&D or sell products, not both simultaneously at this level. Their Tübingen base places them in one of Germany's strongest medical technology clusters. For consortium builders, they offer a credible commercialization pathway: a company that already manufactures and sells endoscopic instruments to hospitals, meaning research outputs have a realistic route to market.

Highlights from their portfolio

• PROSCOPE
  Largest funding (€736K) and most technically ambitious — combines four distinct optical imaging modalities into a single point-of-care colorectal cancer diagnostic instrument.
• Endoo
  Explored magnetic-driven soft-tethered robotic endoscopy, a fundamentally different approach to navigating the GI tract that could reduce patient discomfort.
• WiBEC
  MSCA training network addressing wireless communication inside the human body — a foundational technology for next-generation smart endoscopic capsules and implants.